choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

Zytiga Newsletter
  • Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment 12 Jul 2025 14:00 GMT

    … intensified treatment? What have recent trials like STAMPEDE shown about adding Zytiga (abiraterone … standard treatment plus two years of a hormone therapy drug called Zytiga. Zytiga is … on my own trial, STAMPEDE, and a second trial called LATITUDE, we …

  • Considering the Treatment of mHSPC with Oral Therapies 11 Jul 2025 20:00 GMT

    … Specialists, highlighted treatment optimization and clinical trial insights in … well controlled with medication No family history … therapy [ADT]: abiraterone [Zytiga], apalutamide [Erleada], and enzalutamide … landmark trials led to approval of oral drugs in …

  • FDA grants breakthrough device designation for ArteraAI Prostate tool 10 Jul 2025 16:42 GMT

    … intelligence (AI) “precision medicine tool intended to assist clinicians … data from the STAMPEDE trial (NCT00268476), investigators found … addition of abiraterone acetate (Zytiga) plus prednisone to … do well from standard treatment alone—hormone therapy and …

  • FDA and EMA authorize phase 3 trial of masitinib for mCRPC 07 Jul 2025 18:22 GMT

    Medicines Agency (EMA) have granted authorization for a confirmatory phase 3 trial … 3 study by both the FDA and EMA represents a critical … previous treatment with abiraterone acetate (Zytiga) or who were indicated for treatment docetaxel …

  • Enrollment begins in phase 2 trial of opaganib plus darolutamide in mCRPC 02 Jul 2025 22:09 GMT

    … Urogenital and Prostate Cancer Trials Group Ltd. (ANZUP) … to standard of care treatment with androgen receptor pathway … the placebo-controlled, randomized trial plans to enroll approximately … Erleada), or abiraterone acetate (Zytiga). The study will utilize the …

  • Dr Saraiya on the AMPLITUDE Trial in mCSPC 27 Jun 2025 16:32 GMT

    … combination with abiraterone acetate (Zytiga) plus prednisone (AAP) … Biren Saraiya, MD, medical oncologist at Rutgers Cancer Institute … in the MAGNITUDE trial. Eligible patients with … and hypertension. However, treatment discontinuations due to adverse …

  • FDA Declines to Expand Label for Talazoparib/Enzalutamide in mCRPC 17 Jun 2025 20:51 GMT

    … phase 3 TALAPRO-2 trial (NCT03395197) to support … included prior abirateone acetate (Zytiga) or dectaxel for … www.fda.gov/drugs/drug-approvals-and-databases/fda-approves- … (ENZA) as first-line treatment in unselected patients with metastatic …

  • ASCO 25: J&J combo pill may see wider use in prostate cancer 04 Jun 2025 15:07 GMT

    … the results of a new trial convince regulators. The AMPLITUDE study … ) with BRCA mutations, although the FDA stopped short of giving it … is still a need for treatments that are tailored to patients … from the drug. Akeega is viewed as a successor to Zytiga, a …

  • J&J data support earlier use of combo pill in prostate cancer 03 Jun 2025 18:41 GMT

    … , a pill that combines the active ingredients from the medicines Zejula and Zytiga … .  Some physicians and drugmakers have explored moving treatment to early-stage disease … that broader population,” he said. Trial investigators also analyzed results by …

  • FDA expands darolutamide indication for advanced prostate cancer 04 Jun 2025 22:53 GMT

    trial results showed darolutamide significantly improved radiographic PFS. The FDA … FASCO, professor of medicine and presidential endowed chair … treatments to ADT in this setting — with sister drugs … Erleada, Janssen) and abiraterone (Zytiga, Janssen) — and this …

Satisfied with the content?

Continue to create your account.